Sandbox: wdx: Difference between revisions

Jump to navigation Jump to search
Ssharfaei (talk | contribs)
Ssharfaei (talk | contribs)
Line 24: Line 24:
*Administer [[Iodine-131|radioactive iodine]] therapy in patients with iodine-avid [[bone metastases]]
*Administer [[Iodine-131|radioactive iodine]] therapy in patients with iodine-avid [[bone metastases]]
*Administer [[Iodine-131|radioactive iodine]] therapy in patients with [[Lung|pulmonary]] micrometastases and every 6-12 months
*Administer [[Iodine-131|radioactive iodine]] therapy in patients with [[Lung|pulmonary]] micrometastases and every 6-12 months
== Don'ts ==
*Do not administer radioactive iodine to pregnant women
*Do not administer radioactive iodine to nursing women
*Do not perform surgery with focal “berry-picking” techniques

Revision as of 20:54, 20 November 2017

Do's

Thyroglobulin level monitoring

Cervical ultrasound

18FDG-PET scanning

CT scans

TSH range

  • Maintain serum TSH below 0.1 mU/L in patients with a structural incomplete response to therapy, indefinitely in the absence of specific contraindications
  • Maintain serum TSH between 0.5-2 mU/L in patients with an excellent or indeterminate response to therapy, especially those at low risk for recurrence

Surgery for nodal disease

Radioactive iodine therapy


Don'ts

  • Do not administer radioactive iodine to pregnant women
  • Do not administer radioactive iodine to nursing women
  • Do not perform surgery with focal “berry-picking” techniques